Table 4.
Group 2: Patients clinical characteristics and tumor features defined by imaging
| Group 2 (112 patients) |
|||
|---|---|---|---|
| 2Subgroup A | 2Subgroup BI | 2Subgroup BII | |
| 68 patients (60.7%) | 36 patients (32.1%) | 8 patients (7.2%) | |
| Clinical history | |||
| Previous treatments | 16 (23.5%) | 19 (52.7%) | 2 (25%) |
| Seizures | Short history of seizures | Several seizures | Short history of seizures |
| AEDs | 1 | 2–3 | 1–2 |
| Neurological deficits | Free | 5 mild (13.9%) | 7 mild (87.5%) |
| Tumor characteristics | Sharp margins | Diffuse margins and edema | Large tumors with edema |
| DTI FT available | 22 patients (32.3%) displaced CTS and with a limited infiltration | 17 patients (47.2%) displaced and highly infiltrated CST | 5 patients (62.5%) Significantly dislocating and infiltrating the motor area and tract |
| Histological diagnosis | 54 LGG (79.4%) and 14 HGG (20.6%) | 20 LGG (55.6%) and 16 HGG (44.4%) | 8 HGG (progressive LGG) |
Abbreviations: AEDs, antiepileptic drugs; DTI-FT, diffusion tensor imaging with fiber tractography; HGG, high-grade glioma; LGG, low-grade glioma